Bio-PARK

Boya Holding Group goes abroad to build overseas precision medical clinical research center

Boya Holding Group goes abroad to build overseas precision medical clinical research center

(Summary description)On May 4th, Boya Holding Group and Japan Fujita Health and Health University held a strategic cooperation signing ceremony at the headquarters of Wuxi Boya Holding Group in China. Xu Zhongyuan, deputy director of Wuxi Science and Technology Bureau, Shi Songzhe, deputy director of the Bureau of Commerce, deputy director of the Health Planning Commission, Han Xiaofeng, dean of the Medical College of Jiangnan University, Ji Tingliang, deputy director of the Taihu National Tourism Resort Management Committee, and Wuxi major media attended the event. Second signing ceremony. Dr. Hoshinaga, President of Fujita Health and Medical University, Dr. Iwata, President of Fujita Health and Medical University Hospital, Dr. Xu Xiaotong, Chairman of Boya Holding Group, and Wang Mo, Vice President, signed the contract on behalf of both parties.

Information

On May 4th, Boya Holding Group and Japan Fujita Health and Health University held a strategic cooperation signing ceremony at the headquarters of Wuxi Boya Holding Group in China. Xu Zhongyuan, deputy director of Wuxi Science and Technology Bureau, Shi Songzhe, deputy director of the Bureau of Commerce, deputy director of the Health Planning Commission, Han Xiaofeng, dean of the Medical College of Jiangnan University, Ji Tingliang, deputy director of the Taihu National Tourism Resort Management Committee, and Wuxi major media attended the event. Second signing ceremony. Dr. Hoshinaga, President of Fujita Health and Medical University, Dr. Iwata, President of Fujita Health and Medical University Hospital, Dr. Xu Xiaotong, Chairman of Boya Holding Group, and Wang Mo, Vice President, signed the contract on behalf of both parties.

The two sides will establish a strategic cooperation intention and will establish the Fujita Boya Precision Medical Center in the affiliated hospital of Fujita Health and Medical University in Japan to give full play to their respective advantages and carry out clinical application research and training of health personnel focusing on precision medical technology and fully automatic operating room medical equipment. And medical technology exchanges, etc., to promote the clinical and technical exchanges and academic exchanges between Chinese and Japanese specialists, medical management personnel training, and promote the exchange of medical personnel between the two sides. It is reported that the center will be the first precision medical center set up by Boya Holding Group in the world and an important step in the global strategic layout of Boya Holding Group. In February of this year, Boyaa Holdings Group just spent $15 million to acquire Cesca Therapeutics (NASDAQ:KOOL), a NASDAQ-listed global core manufacturer of stem cell automated separation equipment. This cooperation with Japanese universities can be described as another big move by Boya overseas.

At the meeting, Director of the Health Planning Commission, Mr. Han, delivered a speech. He said that Boya Holding Group is a leading enterprise in the field of biotechnology in China. It is an honor of Wuxi. This time, it has been signed into a global precision medical field with Fujita Health and Health University. Union is a very epoch-making event in the field of health care. It is hoped that both sides will take advantage of their respective advantages and jointly explore effective methods for disease control, prevention and treatment in this field. With this platform, we will learn the advanced experience and technology of the affiliated hospital of Fujita Health and Health University and accelerate the development of the entire precision medical system. Finally, Director Han said that he would give full support to this work. Xu Bureau of Science and Technology Bureau said that Boyaa Holding Group is second to none in Wuxi bio-enterprises in terms of technology, scale and speed of development. Wuxi government actively promotes extensive cooperation between industry, academia and research, and gives strong support to international cooperation in cutting-edge technology. The cooperation between Boya and Fujita hopes to make efforts in international reporting in biotechnology and clinical applications in the future, and congratulations on this cooperation to achieve fruitful results. Director of the Taihu Lake Resort Management Committee introduced the development of the resort and Mashan Biological Outsourcing Zone. He said that the Boya Holding Group settled in the Mashan Biological Outsourcing Zone, which is a very precious “fate”. Director Ji hopes to take this opportunity to cooperate. Dr. Hoshinaga, President of Fujita Health and Health University, and Dr. Iwata, Dean of the Affiliated Hospital, exchanged ideas with the resort. He congratulated the successful cooperation of the project.

Dr. Hoshinaga and Dr. Xu Xiaotong, the president of Fujita Health and Health University, respectively delivered speeches and introduced the development of their respective institutions and enterprises. Fujita Health and Medical University has a history of nearly 50 years, and currently ranks first in the comprehensive medical colleges in Japan. The academic status of each department is second to none in Japan. Dr. Xu Xiaotong said that Boya Holding Group is a company with a core of technological innovation and model innovation, and is committed to building a global life sciences research collaboration platform. Boya's goal is to achieve excellence in technology and to establish a platform for cooperation around the world. This cooperation is a bilateral mutually beneficial cooperation, an attempt to liberalize liberal arts technology, and a good opportunity to learn from Japan's health care system.

On the day before the signing, Dr. Hoshinaga, President of Fujita Health and Medical University, and Iwata, Dean of the Hospital of Fujita Health and Health University, accompanied by Dr. Xu Xiaotong, Chairman of Boya Health and Health, visited the exhibition hall and laboratory of Boya Holding Group and International Stem Cell Joint Research Center. Dr. Hoshinaga The high standards and advanced technology of Boyaa Labs have been greatly appreciated.

The signing of this cooperation agreement marks the beginning of deepening cooperation between the two parties, which will greatly promote the technological innovation of Boya Holding Group in the field of precision medicine, and will also promote practical cooperation between China and Japan in medical personnel training and medical technology exchange. To a good promotion. Precision medicine is considered to be the third revolution in modern medicine and has attracted the attention of more and more developed countries. As a forward-looking company, Boya is committed to promoting the development of precision medicine in China for the benefit of more people.

 

link:

The three teaching hospitals under the Fujita Health and Medical University have a total of 2,176 beds. The Fujita First Affiliated Hospital is the largest and largest hospital in Japan. It is also the largest teaching and internship hospital in Japan, with a large number and leading technology. Medical equipment and medical equipment, the hospital ranks among the top in Japan in terms of organ transplantation, minimally invasive surgery, and radiology. The affiliated hospital of Fujita Health and Health University ranks first in the world in terms of management systems and medical personnel training. (Japan Fujita Health and Medical University official website:www.fujita-hu.ac.jp)

At present, Boyaa Holding Group has established five business divisions, namely (1) Boya Stem Cell Division, (2) Boya Gene Division, (3) Boya Medical Division, (4) Boya Pharmaceutical Division, and (5) Peking University Boya Institute of Translational Medicine, covering eight core businesses of stem cell storage and clinical applications, beauty and anti-aging, oncology biotherapy, high-end medical and health management, animal cloning, genetic testing and precision medicine, drug development and disease model research Module.

new

signing ceremony

新闻

Han Xiaofeng, deputy director of the Wuxi Municipal Health Planning Commission

new

Ji Tingliang, deputy director of the Taihu National Tourism Resort Management Committee

new

Xu Zhongyuan, deputy director of Wuxi Science and Technology Bureau

new

Dr. Hoshinaga, President of Fujita Health and Health University

new

Dr. Xu Xiaotong, Chairman of Boya Holding Group, delivered a speech

new

Dr. Hoshinaga, President of Fujita Health and Medical University, and Iwata, Dean of the Affiliated Hospital, visited the Boya showroom

 

(Boya Xueyuan)